125 related articles for article (PubMed ID: 38913635)
1. A homogeneous time-resolved fluorescence screen to identify SIRT2 deacetylase and defatty-acylase inhibitors.
Yang J; Cassel J; Boyle BC; Oppong D; Ahn YH; Weiser BP
PLoS One; 2024; 19(6):e0305000. PubMed ID: 38913635
[TBL] [Abstract][Full Text] [Related]
2. High-Throughput Screening Identifies Ascorbyl Palmitate as a SIRT2 Deacetylase and Defatty-Acylase Inhibitor.
Hong JY; Cassel J; Yang J; Lin H; Weiser BP
ChemMedChem; 2021 Nov; 16(22):3484-3494. PubMed ID: 34382754
[TBL] [Abstract][Full Text] [Related]
3. Substrate-Dependent Modulation of SIRT2 by a Fluorescent Probe, 1-Aminoanthracene.
Bi D; Yang J; Hong JY; Parikh P; Hinds N; Infanti J; Lin H; Weiser BP
Biochemistry; 2020 Oct; 59(40):3869-3878. PubMed ID: 32941003
[TBL] [Abstract][Full Text] [Related]
4. Development of Peptide-Based Sirtuin Defatty-Acylase Inhibitors Identified by the Fluorescence Probe, SFP3, That Can Efficiently Measure Defatty-Acylase Activity of Sirtuin.
Kawaguchi M; Ieda N; Nakagawa H
J Med Chem; 2019 Jun; 62(11):5434-5452. PubMed ID: 31117516
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel small molecule that inhibits deacetylase but not defatty-acylase reaction catalysed by SIRT2.
Kudo N; Ito A; Arata M; Nakata A; Yoshida M
Philos Trans R Soc Lond B Biol Sci; 2018 Jun; 373(1748):. PubMed ID: 29685974
[TBL] [Abstract][Full Text] [Related]
6. Effects of Dimerization on the Deacylase Activities of Human SIRT2.
Yang J; Nicely NI; Weiser BP
Biochemistry; 2023 Dec; 62(23):3383-3395. PubMed ID: 37966275
[TBL] [Abstract][Full Text] [Related]
7. 2-(Methyl(phenyl)amino)-N-(phenyloxyphenyl)acetamide structural motif representing a framework for selective SIRT2 inhibition.
Kaya SG; Eren G; Massarotti A; Bakar-Ates F; Ozkan E; Gozelle M; Ozkan Y
Drug Dev Res; 2024 Jun; 85(4):e22224. PubMed ID: 38867474
[TBL] [Abstract][Full Text] [Related]
8. A novel sirtuin 2 (SIRT2) inhibitor with p53-dependent pro-apoptotic activity in non-small cell lung cancer.
Hoffmann G; Breitenbücher F; Schuler M; Ehrenhofer-Murray AE
J Biol Chem; 2014 Feb; 289(8):5208-16. PubMed ID: 24379401
[TBL] [Abstract][Full Text] [Related]
9. HaloTag-Targeted Sirtuin-Rearranging Ligand (SirReal) for the Development of Proteolysis-Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2)*.
Schiedel M; Lehotzky A; Szunyogh S; Oláh J; Hammelmann S; Wössner N; Robaa D; Einsle O; Sippl W; Ovádi J; Jung M
Chembiochem; 2020 Dec; 21(23):3371-3376. PubMed ID: 32672888
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton.
Sakai T; Matsumoto Y; Ishikawa M; Sugita K; Hashimoto Y; Wakai N; Kitao A; Morishita E; Toyoshima C; Hayashi T; Akiyama T
Bioorg Med Chem; 2015 Jan; 23(2):328-39. PubMed ID: 25515955
[TBL] [Abstract][Full Text] [Related]
11. X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells.
Yang LL; Wang HL; Zhong L; Yuan C; Liu SY; Yu ZJ; Liu S; Yan YH; Wu C; Wang Y; Wang Z; Yu Y; Chen Q; Li GB
Eur J Med Chem; 2018 Jul; 155():806-823. PubMed ID: 29957526
[TBL] [Abstract][Full Text] [Related]
12. Discovery of New SIRT2 Inhibitors by Utilizing a Consensus Docking/Scoring Strategy and Structure-Activity Relationship Analysis.
Huang S; Song C; Wang X; Zhang G; Wang Y; Jiang X; Sun Q; Huang L; Xiang R; Hu Y; Li L; Yang S
J Chem Inf Model; 2017 Apr; 57(4):669-679. PubMed ID: 28301150
[TBL] [Abstract][Full Text] [Related]
13. Unexpected small molecules as novel SIRT2 suicide inhibitors.
Chen X; Zou Y; Wang J; Cao Z; Liu J; Li Y; Zhao Y; He B
Bioorg Med Chem; 2020 Mar; 28(6):115353. PubMed ID: 32061485
[TBL] [Abstract][Full Text] [Related]
14. Direct Comparison of SIRT2 Inhibitors: Potency, Specificity, Activity-Dependent Inhibition, and On-Target Anticancer Activities.
Spiegelman NA; Price IR; Jing H; Wang M; Yang M; Cao J; Hong JY; Zhang X; Aramsangtienchai P; Sadhukhan S; Lin H
ChemMedChem; 2018 Sep; 13(18):1890-1894. PubMed ID: 30058233
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, in-vitro evaluation and molecular docking studies of novel indole derivatives as inhibitors of SIRT1 and SIRT2.
Manjula R; Gokhale N; Unni S; Deshmukh P; Reddyrajula R; Srinivas Bharath MM; Dalimba U; Padmanabhan B
Bioorg Chem; 2019 Nov; 92():103281. PubMed ID: 31561106
[TBL] [Abstract][Full Text] [Related]
16. Discovery of (5-Phenylfuran-2-yl)methanamine Derivatives as New Human Sirtuin 2 Inhibitors.
Wang L; Li C; Chen W; Song C; Zhang X; Yang F; Wang C; Zhang Y; Qian S; Wang Z; Yang L
Molecules; 2019 Jul; 24(15):. PubMed ID: 31357491
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous Inhibition of SIRT2 Deacetylase and Defatty-Acylase Activities via a PROTAC Strategy.
Hong JY; Jing H; Price IR; Cao J; Bai JJ; Lin H
ACS Med Chem Lett; 2020 Nov; 11(11):2305-2311. PubMed ID: 33214845
[TBL] [Abstract][Full Text] [Related]
18. Virtual screening approach of sirtuin inhibitors results in two new scaffolds.
Kokkonen P; Kokkola T; Suuronen T; Poso A; Jarho E; Lahtela-Kakkonen M
Eur J Pharm Sci; 2015 Aug; 76():27-32. PubMed ID: 25936698
[TBL] [Abstract][Full Text] [Related]
19. Molecular docking and dynamics simulation, receptor-based hypothesis: application to identify novel sirtuin 2 inhibitors.
Sakkiah S; Thangapandian S; Park C; Son M; Lee KW
Chem Biol Drug Des; 2012 Aug; 80(2):315-27. PubMed ID: 22564257
[TBL] [Abstract][Full Text] [Related]
20. Discovery of 2-((4,6-dimethylpyrimidin-2-yl)thio)-N-phenylacetamide derivatives as new potent and selective human sirtuin 2 inhibitors.
Yang L; Ma X; Yuan C; He Y; Li L; Fang S; Xia W; He T; Qian S; Xu Z; Li G; Wang Z
Eur J Med Chem; 2017 Jul; 134():230-241. PubMed ID: 28415012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
